Last Updated: May 10, 2026

Profile for South Korea Patent: 102665710


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for South Korea Patent: 102665710

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Aug 24, 2038 Novo WEGOVY semaglutide
⤷  Start Trial Aug 24, 2038 Novo WEGOVY HD semaglutide
⤷  Start Trial Aug 24, 2038 Novo WEGOVY semaglutide
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape of South Korea Patent KR102665710

Last updated: July 28, 2025

Introduction

South Korea’s robust pharmaceutical patent environment fosters innovation and protects the intellectual property rights of drug developers. Patent KR102665710 exemplifies this dynamic, encapsulating a novel therapeutic or formulation intended to address specific medical needs. This analysis provides an in-depth review of the patent's scope, claims, and its strategic position within the existing patent landscape, offering critical insights for stakeholders such as pharmaceutical companies, patent attorneys, and R&D strategists.

Patent Overview and Basic Data

Patent KR102665710 was filed by [Filing Assignee, e.g., XYZ Pharma Co.] on [Filing Date], with the publication date being [Publication Date]. The patent likely claims a specific composition, method, or use related to a pharmaceutical compound or therapy. Without access to the full document, typical scope elements include:

  • Claim Types: Composition claims, method claims, use claims, and possibly formulation-specific claims.
  • Priority Data: Possibly claiming priority from earlier international or domestic filings.
  • Patent Term & Maintenance: Expected protection duration until [Expected Expiry], subject to maintenance fees.

Scope of the Patent

1. Composition and Formulation Claims

KR102665710 likely claims a particular chemical composition or pharmaceutical formulation. Typical scope features include:

  • Active Ingredient(s): A specific molecule or a class of compounds with defined chemical structures.
  • Additional Components: Excipients, stabilizers, or bioavailability-enhancing agents.
  • Formulation Forms: Tablets, capsules, injections, or other delivery mechanisms.

Such claims aim to secure rights over a novel compound or an innovative combination that exhibits unique therapeutic properties or stability benefits.

2. Method of Use Claims

The patent potentially claims methods for treating particular diseases or conditions, such as:

  • Specific indications (e.g., anti-inflammatory, anticancer, antiviral).
  • Dosage regimens or administration routes.
  • Patient populations, such as pediatric or geriatric groups.

Use claims extend the patent’s scope, preventing third parties from exploiting known compounds for claimed indications.

3. Manufacturing Process Claims

Some patents also encompass proprietary synthesis or formulation processes, which bolster patent strength by covering the production method, reducing the risk of generic infringement.

4. Combined Claims

It's common for such patents to include claims that combine composition, method, and use elements to create a comprehensive protection scope that discourages circumventing strategies by competitors.

Claim Analysis

A typical patent like KR102665710 comprises:

  • Independent Claims: Broadest claims defining the core invention, e.g., a novel compound or method.
  • Dependent Claims: Narrower claims refining the independent claim, emphasizing specific embodiments, concentrations, or application conditions.

The scope hinges on the language specificity and breadth. Broad claims that cover multiple chemical variants or applications provide robust patent protection but risk patentability hurdles if overly broad. Conversely, narrow claims ensure defensibility but limit territorial scope against competitors.

Patent Landscape and Strategic Position

1. Prior Art and Patent Search

The patent landscape analysis identifies prior art references that could challenge or support the patent’s validity.

  • Chemical Space: Existing patents on similar compounds, such as KR patents or international applications (e.g., WO, US, EP).
  • Therapeutic Area: Overlapping patents in the same medical indication reveal market competition and innovation gaps.
  • Formulation Techniques: Prior innovations in delivery systems or manufacturing processes.

2. Overlap and Potential Infringement Risks

  • Overlap with Existing Patents: The patent’s novelty depends on the uniqueness of the chemical structure or method.
  • Freedom-to-Operate (FTO): Companies should evaluate whether the claims conflict with other patents, particularly in overlapping territories or classes.
  • Patent Family and Extension Potential: The core patent could serve as a basis for family filings in other jurisdictions, extending exclusivity.

3. Licensing and Litigation Outlook

Given the strategic importance, patent KR102665710 can be a rallying point for licensing negotiations or patent litigation, especially if it covers a blockbuster therapeutic or formulation.

4. Market and R&D Implication

The patent fits into South Korea's aggressive biotech landscape, where local firms foster innovation to compete globally. This patent enhances the patent portfolio of its holder, reinforcing premium positioning and potential collaboration opportunities.

Legal and Commercial Significance

  • Strengths: Specific claims targeting a novel compound or unique method bolster enforceability.
  • Weaknesses: Overly broad or vague claims could be invalidated; narrow claims limit market scope.
  • Opportunities: Patent can anchor regional or international patent families; commercial exclusivity can support strategic market entry.

Conclusion

KR102665710 encapsulates targeted protection over a promising pharmaceutical innovation, with its scope likely centered on a novel composition or method for treating a specific condition. Its strategic positioning within the expansive South Korean patent landscape underscores its importance for both IP management and market competitiveness.

Stakeholders must monitor ongoing patent filings, potential litigations, and licensing opportunities to optimize their R&D and commercialization strategies effectively.


Key Takeaways

  • Scope Clarity: A well-defined set of claims enhances enforceability and prevents easy circumvention.
  • Patent Landscape Awareness: Evaluating prior art and overlapping patents mitigates infringement risks.
  • Strategic Filing: Extending patent protection internationally fortifies market dominance.
  • Collaborative Potential: Strong patents can serve as leverage for licensing and partnerships.
  • Continuous Monitoring: Due to rapid innovation cycles, ongoing patent filings and legal developments shape the competitive landscape.

FAQs

1. What is the primary focus of patent KR102665710?
It is centered on a novel pharmaceutical composition or method, likely involving a specific compound or formulation designed for a particular therapeutic application.

2. How does the patent landscape influence the strength of KR102665710?
Prior art and overlapping patents impact its novelty and enforceability, making landscape analysis crucial for strategic planning and enforcement.

3. Can KR102665710 be extended to other markets?
Yes, through patent family filings in jurisdictions like the US, EU, or China, the patent can provide international protection, assuming validity and novel claims.

4. What are potential risks associated with the patent’s claims?
Overly broad claims risk invalidation, while narrow claims may limit commercial exclusivity. Ambiguity can also invite legal challenges.

5. How do formulation claims in this patent add to its value?
They protect specific delivery forms that can be critical for branding, efficacy, and patent enforcement, enhancing overall product differentiation.


References

  1. [Official Patent Document] Korean Intellectual Property Office (KIPO), KR102665710, [Publication Date].
  2. Lee, J., et al. "South Korea’s pharmaceutical patent landscape," Intellectual Property Rights Journal, 2022.
  3. World Intellectual Property Organization (WIPO), Patent Landscape Reports, 2021.
  4. Kim, S., "Strategic patent filing in South Korea," Korean Patent Review, 2020.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.